MedPath

University of Zurich

University of Zurich logo
🇨🇭Switzerland
Ownership
Private
Established
1833-04-29
Employees
5K
Market Cap
-
Website
http://www.uzh.ch

Investigation of Gait Parameters in Health and Neurological Disease Under Varying Locomotor Conditions

Recruiting
Conditions
Gait Analysis in Neurological Disorders
First Posted Date
2014-06-17
Last Posted Date
2024-11-14
Lead Sponsor
University of Zurich
Target Recruit Count
340
Registration Number
NCT02165787
Locations
🇨🇭

University of Zurich, Zurich, Switzerland

Sacral Neuromodulation for Neurogenic LUT Dysfunction

Not Applicable
Completed
Conditions
Refractory Neurogenic LUTD
Interventions
Device: Turning ON the neuromodulator
Device: Turning OFF the neuromodulator
First Posted Date
2014-06-17
Last Posted Date
2018-01-09
Lead Sponsor
University of Zurich
Target Recruit Count
61
Registration Number
NCT02165774
Locations
🇨🇭

Cantonal Hospital of St. Gallen, St. Gallen, Saint Gallen, Switzerland

🇨🇭

University of Zurich, Balgrist University Hospital, Spinal Cord Injury Center, Zurich, Switzerland

🇨🇭

Swiss Paraplegic Centre Nottwil, Nottwil, Luzern, Switzerland

and more 1 locations

Is COPD a Risk Factor for Cardiovascular Disease?

Completed
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2014-06-12
Last Posted Date
2015-06-03
Lead Sponsor
University of Zurich
Target Recruit Count
162
Registration Number
NCT02162095
Locations
🇨🇭

University Hospital Zurich, Pulmonary Division, Zurich, Switzerland

Comparative Study of the Therapy of Solar Lentigines With a Q-switched Rubin Laser Versus a Bleaching Cream

Not Applicable
Completed
Conditions
Solar Lentigines
Interventions
Device: Q-switched SINON Ruby Laser
Drug: Pigmanorm Cream
First Posted Date
2014-06-03
Last Posted Date
2014-12-16
Lead Sponsor
University of Zurich
Target Recruit Count
15
Registration Number
NCT02153697
Locations
🇨🇭

University Hospital Zurich, Division of Dermatology, Zurich, Switzerland

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep

Phase 4
Conditions
Precapillary Pulmonary Hypertension
Interstitial Lung Disease
Interventions
Behavioral: Moderate altitude sojourn
Behavioral: Low altitude sojourn
Drug: Sham oxygen (room air)
First Posted Date
2014-05-30
Last Posted Date
2020-02-06
Lead Sponsor
University of Zurich
Target Recruit Count
50
Registration Number
NCT02150616
Locations
🇨🇭

University Hospital Zurich, Pulmonary Division, Zurich, Switzerland

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep

Phase 4
Completed
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
Drug: sham oxygen (room air)
First Posted Date
2014-05-30
Last Posted Date
2019-01-29
Lead Sponsor
University of Zurich
Target Recruit Count
32
Registration Number
NCT02150590
Locations
🇨🇭

University Hospital Zurich, Pulmonary Division, Zurich, Switzerland

Probing Neural Circuitry for the Control of Movement

Completed
Conditions
Neurological Movement Disorders
First Posted Date
2014-05-30
Last Posted Date
2022-08-16
Lead Sponsor
University of Zurich
Target Recruit Count
250
Registration Number
NCT02150642
Locations
🇨🇭

University of Zurich, Zurich, Switzerland

Investigating Kinematic and Electromyographic Changes After SCI and Their Relation to Clinical and Functional Outcome

Completed
Conditions
Spinal Cord Injury
First Posted Date
2014-05-30
Last Posted Date
2021-02-16
Lead Sponsor
University of Zurich
Target Recruit Count
161
Registration Number
NCT02150629
Locations
🇨🇭

Balgrist University Hospital, Zurich, Switzerland

Teeth and Jaw Misalignment in Patients Suffering From Congenital Fourth Cranial Nerve Palsy

Conditions
Fourth Cranial Nerve Palsy
Interventions
Other: teeth molding
First Posted Date
2014-05-29
Last Posted Date
2014-05-29
Lead Sponsor
University of Zurich
Target Recruit Count
50
Registration Number
NCT02149355
Locations
🇨🇭

UniversityHospital Zurich, Zurich, ZH, Switzerland

Antiacne Medications Pseudotumor Cerebri

Phase 4
Conditions
Optic Disc Swelling
Interventions
Other: Retinal nerve fibre layer measurement
First Posted Date
2014-05-29
Last Posted Date
2014-05-29
Lead Sponsor
University of Zurich
Target Recruit Count
310
Registration Number
NCT02149615
Locations
🇨🇭

University Hospital Zurich, Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath